Search

everythinglearnresearchcommunity

for

Search:↓

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Older age and existing health conditions increase COVID-19 death risk.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Older age and existing health issues increase COVID-19 death risk.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Age, health conditions, race, and gender affect COVID-19 risk.

People with alopecia areata may have a higher risk of hearing loss.